Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.
Eren OC, Bagci P, Balci S, Ohike N, Saka B, Sokmensuer C, Leblebici CB, Xue Y, Reid MD, Krasinskas AM, Kooby D, Maithel SK, Sarmiento J, Cheng JD, Taskin OC, Kapran Y, Tarcan ZC, Luchini C, Scarpa A, Basturk O, Adsay NV.
Eren OC, et al. Among authors: taskin oc.
Ann Surg Oncol. 2024 Oct;31(10):7001-7011. doi: 10.1245/s10434-024-15632-y. Epub 2024 Jul 2.
Ann Surg Oncol. 2024.
PMID: 38955993
Free PMC article.